POOR SLEEP quality was consistently associated with greater symptom burden in premenstrual dysphoric disorder (PMDD), a systematic review has found, supporting closer attention to sleep when assessing the condition.
However, the evidence cannot determine whether disturbed sleep worsens PMDD, results from its symptoms or reflects a relationship operating in both directions.
Researchers searched three databases for English-language studies published between January 2013 and December 2024. Six studies involving 1,081 participants across Taiwan, India and Canada were included, although only approximately 249 participants met PMDD criteria.
Diagnosis and sleep assessment varied substantially. Some studies confirmed PMDD through prospective symptom tracking, whereas others used screening questionnaires. Most sleep measurements were self-reported, and the findings were synthesised narratively rather than pooled statistically.
Poorer sleep co-occurred with fatigue, insomnia, difficulties regulating emotions and impaired executive functioning, particularly during the late luteal phase before menstruation. All six studies had concerns about participant representativeness.
These findings need to be interpreted as associations rather than evidence that treating sleep disturbance will reduce the underlying disorder. A consistent pattern across studies can support further investigation without identifying the direction or mechanism of an effect.
The review’s practical message is that sleep deserves consideration alongside emotional and physical symptoms. A discussion that separates difficulty falling asleep, disrupted sleep, excessive sleepiness and daytime fatigue may provide a clearer account of the problems an individual experiences.
Timing also matters. Recording sleep and symptoms across the cycle could help distinguish a recurring premenstrual pattern from difficulties that persist throughout the month. This would provide more useful clinical information than assuming every sleep complaint has the same relationship to menstruation.
The evidence does not yet establish a preferred sleep-focused treatment for PMDD. In particular, an association between better sleep and fewer symptoms should not be presented as proof that a sleep intervention will produce the same result.
Stronger research would assess sleep objectively, confirm diagnoses prospectively and follow participants across multiple cycles. Controlled intervention trials could then test whether improving sleep changes symptoms, functioning or quality of life, rather than simply demonstrating that these outcomes occur together.
For now, the findings offer a reason to include sleep in a comprehensive assessment and a direction for future research, while leaving the effectiveness of sleep-targeted treatment unresolved.
Reference
Omiwole M et al.Premenstrual dysphoric disorder and sleep quality: a systematic review. Reprod Female Child Health. 2026;5:e70102. doi:10.1002/rfc2.70102.
Featured image: Rawpixel.com on AdobeStock
Adobe Stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
